HIGHLIGHTS
- who: Adrian Keogh and collaborators from the Visceral and Transplantation Surgery, Department of Clinical Research, University of Bern, Bern have published the paper: A Novel Anti-Hepatitis C Virus and Antiproliferative Agent Alters Metabolic Networks in HepG2 and Hep3B Cells, in the Journal: (JOURNAL)
- how: Both cell lines were tested for mycoplasma contamination and only lines testing negative were used in the study.
- future: Future studies of drug effects on cultured tumor cells should include a metabolomic component to understand the effect of the drugs on intermediary_metabolism especially if such studies are part . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.